ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
2,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
4,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
6,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
8,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
11,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
13,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
14,1,Headache,Headaches NEC,Headaches,Nerv,N
15,1,Acne,Acnes,Skin appendage conditions,Skin,N
16,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
16,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
17,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
18,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
18,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
19,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
20,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
21,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
24,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
24,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
24,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
24,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
25,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
26,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
28,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
29,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
29,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
30,1,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
30,2,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
31,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
31,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
31,3,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
31,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
31,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
31,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
31,7,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
31,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
31,9,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
31,10,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
31,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
31,12,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
31,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,14,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
31,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,16,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
32,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
32,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
33,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
33,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
34,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
34,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
35,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
35,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
35,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
36,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
36,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
36,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
36,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
37,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
38,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
38,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
38,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
